Catalyst Pharmaceuticals, Inc.
Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating neuromuscular and neurological diseases. Our mission is to improve the lives of patients with rare and ultra-rare diseases such as Lambert-Eaton myasthenic syndrome (LEMS), Congenital Myasthenic Syndromes (CMS), MuSK Myasthenia Gravis and Spinal Muscular Atrophy (SMA). To learn more, please visit our website at www.catalystpharma.com
First Time Exhibitor No